Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix, Illumina Ink Alliance

NEW YORK (GenomeWeb News) – CombiMatrix disclosed in a filing today with the US Securities and Exchange Commission that it has entered into a supply agreement with Illumina.

The filing offers few details of the agreement, and CombiMatrix officials were unavailable for comment by the time this article was published.

The Mukilteo, Wash.-based firm said that it has agreed to sell to Illumina certain CombiMatrix products for use in or sale with Illumina products and applications. The deal is subject to certain minimum purchase order commitments, and Illumina has an option to purchase exclusive rights to use and sell those CombiMatrix products in a designated field, according to the filing.

A few weeks ago, CombiMatrix said that it had hired investment bank Robert W. Baird as a financial and strategic advisor to help the firm review "certain strategies aimed at unlocking shareholder value and creating synergistic relationships."

The Scan

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.

Plan Rebuffed

The Associated Press reports China has rejected the World Health Organization's proposal to include the lab-leak theory in the next phase of its investigation into the origins of SARS-CoV-2.